UPK2 and urinary bladder cancer: Additionally, in the uroplakin II-SV40T transgenic model, castration reduced microvessel density in bladder tumors and increased the expression of an anti-angiogenic factor TSP-1 [92], indicating the promotion of angiogenesis by AR activation in bladder cancer.